• NJ- Kronos Health LLC (KHL) and Ubuntu Research Inc (URI) have entered into a Memorandum of Understanding (MoU) on April 5, 2024, to establish a strategic partnership aimed at advancing clinical research services for emerging oncology biotech companies. The MoU outlines the collaborative efforts of KHL and URI in working together to achieve common objectives related to the Joint Collaboration for Clinical Research Services Project. Both parties are committed to leveraging their expertise and resources to streamline the drug development process and accelerate the pace of delivering innovative therapies to cancer patients.
  • Under the terms of the MoU, KHL and URI will collaborate on various aspects of the project, including:
    • Strategic, clinically focused talent acquisition and deployment
    • Development stage business operations process standardization
    • Data strategy and digital technology implementation
    • Optimization of financial, material, and labor resource allocation across all aspects of clinical program management
  • KHL will contribute its expertise in bench-to-market strategy, commercial and clinical development, investor relations, and partnership structuring, among other services including:
    • Portfolio planning, lifecycle management, and go-to-market strategy
    • Precision Medicine and Companion Diagnostics Commercial Strategy (This will be huge draw)
    • Investor & BD pitch presentations
    • Market differentiation and impact value analysis (Commercial Readiness and differentiation)

"We are thrilled to formalize our partnership with Ubuntu Research Inc," said Sangeetha Ramsagar, MS, MBA, Founder & CEO of Kronos Health LLC. "Together, we aim to revolutionize the clinical research landscape and drive meaningful advancements in cancer treatment and beyond."

"We are excited to collaborate with Kronos Health LLC to combine our synergies and deep-rooted oncology drug development expertise in clinical research services," said Vishal Mehta, MS, Founder and CEO of Ubuntu Research Inc. "This partnership reflects our shared commitment to improving patient outcomes and advancing medical innovation."

The MoU represents a significant step forward in the collaboration between KHL and URI and lays the foundation for future cooperation in the development and execution of clinical research initiatives.

Sangeetha Ramsagar, Kronos Health

Vishal Mehta, Ubuntu Research